博济医药：全资子公司取得一项发明专利证书

Group 1 - The company Boji Pharmaceutical announced that its wholly-owned subsidiary, Xinglin Traditional Chinese Medicine Technology (Guangzhou) Co., Ltd., has received an invention patent certificate from the National Intellectual Property Administration of China [1] - The patent is titled "A Liver-targeted Alkylating Agent and Its Application" [1] Group 2 - The announcement was made on the evening of December 31 [1] - This development may indicate potential advancements in the company's product offerings and research capabilities in the pharmaceutical sector [1]